Trinity Biotech Plc - ADR
TRIB
Get informed when a big investor buys or sells
+ FollowMarket Cap$6.75M
Close$
$-0.55
180.8% downside
Current Fair Value
180.8% downsideOvervalued by 180.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $6.75 Million |
|---|---|
| Enterprise Value | $139.60 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-2 |
| Beta | 0.93 |
| Outstanding Shares | 18,627,618 |
Return
| Return on Equity | 51.99% |
|---|---|
| Return on Assets | -35.58% |
| Return on Invested Capital | 38.28% |
Valuation & Multiples
| P/E Ratio | -0.32 |
|---|---|
| PEG | -10.82 |
| Price to Sales | 0.34 |
| Price to Book Ratio | -0.17 |
| Enterprise Value to Revenue | 3.18 |
| Enterprise Value to EBIT | -10.12 |
| Enterprise Value to Net Income | -4 |
| Total Debt to Enterprise | 0.99 |
| Debt to Equity | -1.92 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 21, 2026
EPS Estimate
$-0.31
Average shareholder expectationRevenue Estimate
$10.68 M
Average shareholder expectationNext Earnings Call
Expected Date
September 3, 2026
EPS Estimate
$-0.26
Average shareholder expectationRevenue Estimate
$10.31 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 84.64% |
|---|---|
| Total Calls | 28,500▼ 23.18% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 5.75%▲ 1.20% |
|---|---|
| Total Invested | $588,883▼ 12.56% |
| Investors Holding | 25▼ 7.00% |
ESG Score
No data